22nd Century Group, Inc. (NASDAQ:XXII) Short Interest Up 1,933.3% in January

22nd Century Group, Inc. (NASDAQ:XXII) was the recipient of a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 91,500 shares, a growth of 1,933.3% from the December 31st total of 4,500 shares. Based on an average trading volume of 109,400 shares, the days-to-cover ratio is presently 0.8 days. Currently, 19.5% of the company’s shares are short sold.

Institutional Investors Weigh In On 22nd Century Group

A hedge fund recently bought a new stake in 22nd Century Group stock. Anson Funds Management LP acquired a new stake in shares of 22nd Century Group, Inc. (NASDAQ:XXII) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 3,140,452 shares of the biotechnology company’s stock, valued at approximately $691,000. Anson Funds Management LP owned approximately 6.77% of 22nd Century Group at the end of the most recent reporting period. Hedge funds and other institutional investors own 18.06% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently commented on XXII shares. StockNews.com downgraded shares of 22nd Century Group from a “hold” rating to a “sell” rating in a research report on Tuesday, December 31st. Weiss Ratings restated a “sell (e+)” rating on shares of 22nd Century Group in a research note on Saturday, January 18th.

22nd Century Group Stock Down 9.9 %

22nd Century Group stock traded down $0.49 during mid-day trading on Tuesday, reaching $4.45. The stock had a trading volume of 157,158 shares, compared to its average volume of 3,052,195. The company has a 50-day moving average price of $8.09 and a two-hundred day moving average price of $34.92. The company has a market capitalization of $2.45 million, a price-to-earnings ratio of 0.00 and a beta of 1.59. 22nd Century Group has a one year low of $3.90 and a one year high of $581.85. The company has a debt-to-equity ratio of 1.59, a current ratio of 1.09 and a quick ratio of 0.93.

22nd Century Group (NASDAQ:XXII) last issued its quarterly earnings data on Tuesday, November 12th. The biotechnology company reported ($72.90) EPS for the quarter. The company had revenue of $5.95 million during the quarter.

22nd Century Group Company Profile

22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.